JACC. Clinical electrophysiology · 2026
Role of Non-Pulmonary Vein Triggers in Outcomes of First-Time Atrial Fibrillation Ablation.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oraii Alireza, Afzalian Arian, Chaumont Corentin, Rodriguez-Queralto Oriol, Liao Ting-Wei Ernie, Gad Mohamed M, Zaidi Syed Muhammad Mustafa, Zado Erica, Tschabrunn Cory M, Hanumanthu Balaram Krishna J, Hyman Matthew C, Markman Timothy M, Guandalini Gustavo, Kumareswaran Ramanan, Deo Rajat, Riley Michael P, Lin David, Garcia Fermin C, Nazarian Saman, Supple Gregory E, Schaller Robert D, Frankel David S, Callans David J, Dixit Sanjay, Marchlinski Francis E
Аннотация
BACKGROUND: Pulmonary veins (PVs) are major sources of atrial fibrillation (AF) triggers, but patients may also have non-PV (NPV) triggers. Data on the impact of targeting NPV triggers on AF ablation outcomes are limited.
OBJECTIVES: This study aimed to assess the outcome of patients undergoing AF ablation based on their NPV trigger status.
METHODS: Patients undergoing first-time AF ablation using radiofrequency energy between 2018 and 2023 who received trigger provocative maneuvers were included. The provocative maneuvers consisted of cardioversion of AF, incremental isoproterenol infusion (3, 6, 12, and 20-30 μg/min) and/or an atrial burst pacing protocol. NPV triggers were defined as ectopic foci initiating AF, sustained focal atrial tachycardia (AT), or atrioventricular nodal reentrant tachycardia. Recurrence was defined as AF/AT >30 seconds after a 90-day blanking period.
RESULTS: Of 2,315 patients included, 2,046 (88.4%) did not have NPV triggers, 233 (10.1%) had NPV triggers that were ablated, and 36 (1.6%) had NPV triggers that were not targeted or failed localization/ablation attempts. One-year recurrence rate was 29.5% in patients without NPV triggers, 38.2% in those with ablated NPV triggers (adjusted HR: 1.35; 95% CI: 1.08-1.69), and 72.2% in those with untreated NPV triggers (adjusted HR: 3.71; 95% CI: 2.48-5.54). This response pattern remained consistent regardless of NPV trigger subtype (AF vs focal AT) or provocation method (spontaneous vs induced triggers).
CONCLUSIONS: Failure to ablate induced NPV triggers is associated with a high risk of recurrence. Although the ablation of NPV triggers reduces recurrence rates to levels approaching those without such triggers, their presence indicates a modestly worse prognosis.
OBJECTIVES: This study aimed to assess the outcome of patients undergoing AF ablation based on their NPV trigger status.
METHODS: Patients undergoing first-time AF ablation using radiofrequency energy between 2018 and 2023 who received trigger provocative maneuvers were included. The provocative maneuvers consisted of cardioversion of AF, incremental isoproterenol infusion (3, 6, 12, and 20-30 μg/min) and/or an atrial burst pacing protocol. NPV triggers were defined as ectopic foci initiating AF, sustained focal atrial tachycardia (AT), or atrioventricular nodal reentrant tachycardia. Recurrence was defined as AF/AT >30 seconds after a 90-day blanking period.
RESULTS: Of 2,315 patients included, 2,046 (88.4%) did not have NPV triggers, 233 (10.1%) had NPV triggers that were ablated, and 36 (1.6%) had NPV triggers that were not targeted or failed localization/ablation attempts. One-year recurrence rate was 29.5% in patients without NPV triggers, 38.2% in those with ablated NPV triggers (adjusted HR: 1.35; 95% CI: 1.08-1.69), and 72.2% in those with untreated NPV triggers (adjusted HR: 3.71; 95% CI: 2.48-5.54). This response pattern remained consistent regardless of NPV trigger subtype (AF vs focal AT) or provocation method (spontaneous vs induced triggers).
CONCLUSIONS: Failure to ablate induced NPV triggers is associated with a high risk of recurrence. Although the ablation of NPV triggers reduces recurrence rates to levels approaching those without such triggers, their presence indicates a modestly worse prognosis.